Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee hears amendments to Prescription Drug Affordability Board bill; additional reporting and stakeholder seats added
Summary
Senate Bill 357 would refine how the Prescription Drug Affordability Board sets upper payment limits and adds stakeholder representation for rare diseases and oncology; sponsor said amendments add reporting requirements and clarify application to drugs in shortage.
Senate Bill 357, the cross-file of House Bill 424, was presented with amendments that clarify how the Prescription Drug Affordability Board (PDAB) would set upper payment limits, add stakeholder seats representing rare disease and oncology communities, and expand reporting requirements.
Sen. Guile's legislative staff presented the…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
